Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer

NCT01349842 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT01349842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer
Lead sponsor
Institut Curie
Phase
Phase 3
Overall status
Completed
Start date
March 2, 2010
Completion date
November 6, 2018
Enrollment
265 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer ductal infiltrating metastatic